Therefore, eIF4A3 and FUS may constitute key lncRNA-binding proteins that could be part of a pan-cancer molecular mechanism that mediates the tumorigenic properties of most oncogenic lncRNAs and/or generally promotes lncRNA secretion into the systemic circulation from the tumor site. The gene discussed is FUS; the disease is neoplasm.